Document Detail


Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates.
MedLine Citation:
PMID:  18719956     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A pyrosequencing-based method for the rapid detection of isoniazid (INH) and rifampin (RIF) resistance in Mycobacterium tuberculosis was evaluated in clinical practice. The method can detect the INH resistance-causing katG315 mutation, and all mutations in the RIF resistance-determining rpoB core region, in less than 6 h from cultured isolates. The method was first validated with 42 isolates, and was subsequently prospectively evaluated with 91 isolates, including clinical isolates and external quality control assessment strains, over a period of 2.5 years. The pyrosequencing results of clinical isolates were available, on average, 19 days earlier (median 19 days; range 3-43 days) than conventional susceptibility testing results. The composite data showed that the sensitivity of pyrosequencing for detecting resistance correctly was 66.7% for INH and 97.4% for RIF. The specificity of pyrosequencing was 100% for both drugs. Acceptable sensitivity for detecting resistance and the rapidness of pyrosequencing make it a valuable tool in the clinical setting.
Authors:
H J Marttila; J Mäkinen; M Marjamäki; H Soini
Related Documents :
23606066 - Reexamination offusarium graminearum nrrl-13820and nrrl-13852 reported as type a tricho...
19846046 - Comparison of the performance of two mycobacteriophage d29-based protocols for fluoroqu...
16153726 - The use of macroarrays for the identification of mdr mycobacterium tuberculosis.
20966096 - Deletion of the histone-like protein (hlp) from mycobacterium smegmatis results in incr...
8202536 - Proton conduction within the reaction centers of rhodobacter capsulatus: the electrosta...
21645646 - High genetic diversity of hiv-1 was found in men who have sex with men in shijiazhuang,...
Publication Detail:
Type:  Evaluation Studies; Journal Article     Date:  2008-08-22
Journal Detail:
Title:  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology     Volume:  28     ISSN:  1435-4373     ISO Abbreviation:  Eur. J. Clin. Microbiol. Infect. Dis.     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2008-12-24     Completed Date:  2009-02-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804297     Medline TA:  Eur J Clin Microbiol Infect Dis     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  33-8     Citation Subset:  IM    
Affiliation:
Mycobacterial Reference Laboratory, National Public Health Institute, Turku, Finland. johanna.makinen@ktl.fi
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Substitution / genetics
Antitubercular Agents / pharmacology*
Bacterial Proteins / genetics
Catalase / genetics
DNA, Bacterial / chemistry,  genetics*
Drug Resistance, Bacterial*
Humans
Isoniazid / pharmacology*
Microbial Sensitivity Tests / methods
Mutation, Missense
Mycobacterium tuberculosis / drug effects*,  genetics
Prospective Studies
Rifampin / pharmacology*
Sensitivity and Specificity
Sequence Analysis, DNA / methods*
Chemical
Reg. No./Substance:
0/Antitubercular Agents; 0/Bacterial Proteins; 0/DNA, Bacterial; 0/rpoB protein, Mycobacterium tuberculosis; 13292-46-1/Rifampin; 54-85-3/Isoniazid; EC 1.11.1.6/Catalase; EC 1.11.1.6/katG protein, Mycobacterium tuberculosis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Visually guided capture of a moving stimulus by the pigeon (Columba livia).
Next Document:  Probing the influence of myelin and glia on the tensile properties of the spinal cord.